The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
This post first appeared in The New York Times – Business. Read the original article.F.D.A. Confirms Widespread Shortages of Adderall
The New York Times – Business:
Written by
in
